Margaret Pinder1, Musa Jawara2, Lamin B S Jarju3, Kolawole Salami2, David Jeffries2, Majidah Adiamoh2, Kalifa Bojang2, Simon Correa2, Balla Kandeh3, Harparkash Kaur4, David J Conway5, Umberto D'Alessandro6, Steve W Lindsay7. 1. Medical Research Council Unit, Banjul, The Gambia; London School of Hygiene and Tropical Medicine, London, UK; Durham University, Durham, UK. 2. Medical Research Council Unit, Banjul, The Gambia. 3. National Malaria Control Programme, Banjul, The Gambia. 4. London School of Hygiene and Tropical Medicine, London, UK. 5. Medical Research Council Unit, Banjul, The Gambia; London School of Hygiene and Tropical Medicine, London, UK. 6. Medical Research Council Unit, Banjul, The Gambia; Institute of Tropical Medicine, Antwerp, Belgium. 7. London School of Hygiene and Tropical Medicine, London, UK; Durham University, Durham, UK. Electronic address: s.w.lindsay@durham.ac.uk.
Abstract
BACKGROUND: Although many malaria control programmes in sub-Saharan Africa use indoor residual spraying with long-lasting insecticidal nets (LLINs), the two studies assessing the benefit of the combination of these two interventions gave conflicting results. We aimed to assess whether the addition of indoor residual spraying to LLINs provided a significantly different level of protection against clinical malaria in children or against house entry by vector mosquitoes. METHODS: In this two-arm cluster, randomised, controlled efficacy trial we randomly allocated clusters of Gambian villages using a computerised algorithm to LLINs alone (n=35) or indoor residual spraying with dichlorodiphenyltrichloroethane plus LLINs (n=35). In each cluster, 65-213 children, aged 6 months to 14 years, were surveyed at the start of the 2010 transmission season and followed in 2010 and 2011 by passive case detection for clinical malaria. Exposure to parasite transmission was assessed by collection of vector mosquitoes with both light and exit traps indoors. Primary endpoints were the incidence of clinical malaria assessed by passive case detection and number of Anopheles gambiae sensu lato mosquitoes collected per light trap per night. Intervention teams had no role in data collection and the data collection teams were not informed of the spray status of villages. The trial is registered at the ISRCTN registry, number ISRCTN01738840. FINDINGS: LLIN coverage in 2011 was 3510 (93%) of 3777 children in the indoor residual spraying plus LLIN group and 3622 (95.5%) of 3791 in the LLIN group. In 2010, 7845 children were enrolled, 7829 completed passive case detection, and 7697 (98%) had complete clinical and covariate data. In 2011, 7009 children remained in the study, 648 more were enrolled, 7657 completed passive case detection, and 7545 (98.5%) had complete data. Indoor residual spraying coverage per cluster was more than 80% for both years in the indoor residual spraying plus LLIN group. Incidence of clinical malaria was 0.047 per child-month at risk in the LLIN group and 0.044 per child-month at risk in the indoor residual spraying plus LLIN group in 2010, and 0.032 per child-month at risk in the LLIN group and 0.034 per child-month at risk in the indoor residual spraying plus LLIN group in 2011. The incident rate ratio was 1.08 (95% CI 0.80-1.46) controlling for confounders and cluster by mixed-effect negative binomial regression on all malaria attacks for both years. No significant difference was recorded in the density of vector mosquitoes caught in light traps in houses over the two transmission seasons; the mean number of A gambiae sensu lato mosquitoes per trap per night was 6.7 (4.0-10.1) in the LLIN group and 4.5 (2.4-7.4) in the indoor residual spraying plus LLIN group (p=0.281 in the random-effects linear regression model). INTERPRETATION: We identified no significant difference in clinical malaria or vector density between study groups. In this area with high LLIN coverage, moderate seasonal transmission, and susceptible vectors, indoor residual spraying did not provide additional benefit. FUNDING: UK Medical Research Council.
BACKGROUND: Although many malaria control programmes in sub-Saharan Africa use indoor residual spraying with long-lasting insecticidal nets (LLINs), the two studies assessing the benefit of the combination of these two interventions gave conflicting results. We aimed to assess whether the addition of indoor residual spraying to LLINs provided a significantly different level of protection against clinical malaria in children or against house entry by vector mosquitoes. METHODS: In this two-arm cluster, randomised, controlled efficacy trial we randomly allocated clusters of Gambian villages using a computerised algorithm to LLINs alone (n=35) or indoor residual spraying with dichlorodiphenyltrichloroethane plus LLINs (n=35). In each cluster, 65-213 children, aged 6 months to 14 years, were surveyed at the start of the 2010 transmission season and followed in 2010 and 2011 by passive case detection for clinical malaria. Exposure to parasite transmission was assessed by collection of vector mosquitoes with both light and exit traps indoors. Primary endpoints were the incidence of clinical malaria assessed by passive case detection and number of Anopheles gambiae sensu lato mosquitoes collected per light trap per night. Intervention teams had no role in data collection and the data collection teams were not informed of the spray status of villages. The trial is registered at the ISRCTN registry, number ISRCTN01738840. FINDINGS: LLIN coverage in 2011 was 3510 (93%) of 3777 children in the indoor residual spraying plus LLIN group and 3622 (95.5%) of 3791 in the LLIN group. In 2010, 7845 children were enrolled, 7829 completed passive case detection, and 7697 (98%) had complete clinical and covariate data. In 2011, 7009 children remained in the study, 648 more were enrolled, 7657 completed passive case detection, and 7545 (98.5%) had complete data. Indoor residual spraying coverage per cluster was more than 80% for both years in the indoor residual spraying plus LLIN group. Incidence of clinical malaria was 0.047 per child-month at risk in the LLIN group and 0.044 per child-month at risk in the indoor residual spraying plus LLIN group in 2010, and 0.032 per child-month at risk in the LLIN group and 0.034 per child-month at risk in the indoor residual spraying plus LLIN group in 2011. The incident rate ratio was 1.08 (95% CI 0.80-1.46) controlling for confounders and cluster by mixed-effect negative binomial regression on all malaria attacks for both years. No significant difference was recorded in the density of vector mosquitoes caught in light traps in houses over the two transmission seasons; the mean number of A gambiae sensu lato mosquitoes per trap per night was 6.7 (4.0-10.1) in the LLIN group and 4.5 (2.4-7.4) in the indoor residual spraying plus LLIN group (p=0.281 in the random-effects linear regression model). INTERPRETATION: We identified no significant difference in clinical malaria or vector density between study groups. In this area with high LLIN coverage, moderate seasonal transmission, and susceptible vectors, indoor residual spraying did not provide additional benefit. FUNDING: UK Medical Research Council.
Authors: Kate Zinszer; Katia Charland; Sarah Vahey; Deepa Jahagirdar; John C Rek; Emmanuel Arinaitwe; Joaniter Nankabirwa; Kathryn Morrison; Margaux L Sadoine; Marc-Antoine Tutt-Guérette; Sarah G Staedke; Moses R Kamya; Bryan Greenhouse; Isabel Rodriguez-Barraquer; Grant Dorsey Journal: J Infect Dis Date: 2020-01-02 Impact factor: 5.226
Authors: Ellie Sherrard-Smith; Corine Ngufor; Antoine Sanou; Moussa W Guelbeogo; Raphael N'Guessan; Eldo Elobolobo; Francisco Saute; Kenyssony Varela; Carlos J Chaccour; Rose Zulliger; Joseph Wagman; Molly L Robertson; Mark Rowland; Martin J Donnelly; Samuel Gonahasa; Sarah G Staedke; Jan Kolaczinski; Thomas S Churcher Journal: Nat Commun Date: 2022-07-05 Impact factor: 17.694
Authors: Saned Raouf; Arthur Mpimbaza; Ruth Kigozi; Asadu Sserwanga; Denis Rubahika; Henry Katamba; Steve W Lindsay; Bryan K Kapella; Kassahun A Belay; Moses R Kamya; Sarah G Staedke; Grant Dorsey Journal: Clin Infect Dis Date: 2017-08-01 Impact factor: 9.079
Authors: Margaret Pinder; Lesong Conteh; David Jeffries; Caroline Jones; Jakob Knudsen; Balla Kandeh; Musa Jawara; Elisa Sicuri; Umberto D'Alessandro; Steve W Lindsay Journal: Trials Date: 2016-06-03 Impact factor: 2.279